AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Glitaris 7.5 Tablet

Prescription Icon
Prescription Required

Marketer

Eris Lifesciences Ltd

Salt Composition

Pioglitazone (7.5mg)

Overview Glitaris 7.5 Tablet

DiabetiCare 7.5mg tablets are prescribed for adult patients with type 2 diabetes. This medication assists in regulating blood glucose, thereby mitigating the risk of severe diabetic complications such as vision impairment and renal dysfunction. DiabetiCare 7.5mg may be administered independently or in conjunction with other treatments, with or without food. Consistent daily usage at the same time maximizes therapeutic efficacy. Dosage adjustments are determined by your physician based on treatment response. Continued use is crucial, even with controlled blood sugar, as premature discontinuation can elevate glucose levels, potentially leading to kidney damage, blindness, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Commonly reported side effects include headache, sinus inflammation, myalgia, and sore throat. Report any persistent or bothersome side effects to your doctor. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your physician of any history of cardiovascular disease, thyroid disorders, or hormonal imbalances before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Glitaris 7.5 Tablet

There is no text provided to rewrite.

Uses of Glitaris 7.5 Tablet

Managing type 2 diabetes

Major Benefits of Glitaris 7.5 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glitaris 7.5 Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, however, consistent timing is recommended.

Common Side effects of Glitaris 7.5 Tablet:

  • Headache
  • Sore throat
  • Sinus inflammation
  • Muscle pain

How to use Glitaris 7.5 Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glitaris 7.5 Tablet can be consumed with or without food; however, consistent timing is recommended.

How Glitaris 7.5 Tablet works:

Glaritin 7.5mg tablets help manage diabetes. Their mechanism involves enhancing the body's responsiveness to insulin, thereby regulating blood glucose.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glitaris 7.5 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glitaris 7.5 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCAUTION

The use of Glitaris 7.5 Tablet while breastfeeding requires careful consideration. Lactation should be suspended for the duration of maternal treatment and until the medication is fully cleared from the mother's system. Close monitoring of the infant's blood glucose levels is necessary throughout the treatment period.

DrivingDrivingSAFE

Driving ability is typically unaffected by Glitaris 7.5 Tablet.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely take Glitaris 7.5 Tablet without requiring any alteration to the prescribed dosage.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Glitaris 7.5 mg tablets, as dose modification may be necessary. Severe hepatic dysfunction contraindicates Glitaris 7.5 mg tablet use; physician consultation is advised.

What if you forget to take Glitaris 7.5 Tablet :

Omit any missed dose of Glitaris 7.5 Tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glitaris 7.5 Tablet

LabelValue
Chemical Category TZD derivative
Developing Habits No.
Type of Therapy Diabetes medication
Actions PPAR-gamma agonist (thiazolidinedione)

FAQs on Glitaris 7.5 Tablet

Weight gain, potentially dose-dependent, is a common side effect of Glitaris 7.5 Tablet. This may result from fat accumulation or, in patients with heart failure, fluid retention. Close weight monitoring is crucial for heart failure patients taking this medication.
Glitaris 7.5 Tablet may cause fluid retention, potentially worsening or accelerating heart failure. Therefore, doctors typically begin with the lowest dose and gradually increase it, especially in patients with a heart failure risk factor (e.g., prior heart attack, coronary artery disease, advanced age). Concurrent use of Glitaris 7.5 Tablet and insulin increases the risk of heart failure.
Yes, Glitaris 7.5 Tablet can augment metformin in adult patients with type 2 diabetes mellitus, particularly those who are overweight and haven't achieved adequate blood sugar control with metformin monotherapy.
Take Glitaris 7.5 Tablet once daily, at the same time each day if possible, with or without food, as directed by your doctor.
Follow your doctor's instructions regarding Glitaris 7.5 Tablet; diabetes treatment often requires lifelong medication. If you need to discontinue use, consult your doctor for alternative options. Never stop taking it without medical advice, as this could dangerously increase your blood sugar.
Glitaris 7.5 Tablet can raise liver enzyme levels; therefore, regular liver enzyme monitoring is necessary during treatment. Treatment should cease if enzyme levels increase, and the medication shouldn't be given to patients with liver disease.
Glitaris 7.5 Tablet, a thiazolidinedione antidiabetic medication, regulates blood sugar by enhancing insulin utilization. This action improves cellular insulin sensitivity.
Glitaris 7.5 Tablet has been associated with a very rare increased risk of bladder cancer. If you experience hematuria (blood in urine), dysuria (painful urination), or urinary urgency while taking this medication, seek immediate medical attention. This medication is contraindicated in patients with a history of bladder cancer.
Glitaris 7.5 Tablet
76
MRP 88
13% off